Thousands faced delays in accessing cancer treatment last year

Thousands of cancer patients in Ireland experienced delays in receiving vital treatment last year, according to newly released data from the National Cancer Control Programme (NCCP). The figures reveal significant numbers of patients waited beyond recommended timeframes for chemotherapy, radiotherapy, and life-saving surgery.

Treatment Delays Across Cancer Types

HSE guidelines state patients should begin radiotherapy or chemotherapy within 15 working days of being deemed ready for treatment. However, the data shows that 15 per cent of chemotherapy patients and 21 per cent of radiotherapy patients did not meet this target. This translates to 1,356 chemotherapy patients and 1,448 radiotherapy patients facing delays.

Delays also impacted surgical interventions. Nationally, 45 per cent of breast cancer patients (455 individuals) did not receive surgery within the recommended timeframe. Similarly, 39 per cent of lung cancer patients (104 individuals) and over six-in-ten prostate cancer patients (377 individuals) experienced delays exceeding 30 days.

Did You Know? Approximately 35 per cent of radiotherapy equipment is currently out of date.

The Human Cost of Delays

Emma Harte, policy and campaigns manager at the Irish Cancer Society, emphasized the impact of these delays, stating, “Patients who have received the devastating news of their diagnosis deserve the best possible chance of surviving this disease, but delays across the country sadly means patients are not being given that chance.” The Irish Cancer Society is advocating for the NCCP data to be released in real-time to better identify and address these issues.

Sinn Féin health spokesperson David Cullinane, who requested the data through a parliamentary question, accused the Government of allowing a “tiered system of cancer care” to develop due to insufficient funding. He highlighted the anxieties faced by patients, citing examples of individuals in Waterford and Roscommon waiting weeks for chemotherapy. He also noted that delays in diagnostic scans contribute to treatment delays.

Cullinane further explained that capacity failures are impacting the entire cancer care pathway, from initial GP referrals to surgery. He pointed to issues with both the availability and age of equipment, as well as staffing shortages preventing full utilization of existing resources.

Expert Insight: Systemic delays in cancer care, impacting diagnostics, treatment, and surgery, suggest a fundamental strain on resources and staffing. This ripple effect across the entire patient journey underscores the complexity of addressing these challenges and the potential for prolonged uncertainty and anxiety for those affected.

What Could Happen Next

If current trends continue, We see likely that wait times for cancer treatment could remain elevated, potentially impacting patient outcomes. A possible next step could involve increased investment in equipment and staffing, as suggested by David Cullinane. Analysts expect continued advocacy from organizations like the Irish Cancer Society for greater transparency through real-time data reporting. It is also possible that further parliamentary scrutiny will focus on funding levels and resource allocation within the healthcare system.

Frequently Asked Questions

What percentage of radiotherapy patients experienced delays?

21 per cent of radiotherapy patients did not start treatment within the recommended 15-day timeframe, totaling 1,448 people.

What types of surgery were most affected by delays?

Breast cancer surgery experienced delays for 45 per cent of patients (455 individuals), lung cancer surgery for 39 per cent (104 individuals), and prostate cancer surgery for over 60 per cent (377 individuals).

What is the Irish Cancer Society calling for?

The Irish Cancer Society is calling for the NCCP data to be released in real-time on a regular basis, to allow for better identification of patients facing delays and targeted investment.

Considering the challenges highlighted in this report, what role do you believe community support and advocacy can play in improving access to timely cancer care?